Dividendos de Clinuvel Pharmaceuticals
Dividendo controles de criterios 0/6
Clinuvel Pharmaceuticals es una empresa que paga dividendos con una rentabilidad actual de 0.34%.
Información clave
0.3%
Rentabilidad por dividendo
8%
Ratio de pago
| Rentabilidad media de la industria | 2.9% |
| Próxima fecha de pago de dividendos | n/a |
| Fecha ex dividendo | n/a |
| Dividendo por acción | n/a |
| Beneficios por acción | AU$0.60 |
| Rentabilidad por dividendo prevista a 3 años | 0.6% |
Últimas actualizaciones de dividendos
Recent updates
If EPS Growth Is Important To You, Clinuvel Pharmaceuticals (ASX:CUV) Presents An Opportunity
Aug 11
Calculating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jun 27Is Now The Time To Put Clinuvel Pharmaceuticals (ASX:CUV) On Your Watchlist?
May 09Estimating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Mar 24An Intrinsic Calculation For Clinuvel Pharmaceuticals Limited (ASX:CUV) Suggests It's 41% Undervalued
Nov 18Increases to Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Might Cool off for now
Oct 20Is Clinuvel Pharmaceuticals Limited (ASX:CUV) Trading At A 21% Discount?
Jul 30Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Feb 27Does Clinuvel Pharmaceuticals (ASX:CUV) Deserve A Spot On Your Watchlist?
Dec 14This Is The Reason Why We Think Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Might Be Underpaid
Nov 03A Look At The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Sep 23Here's Why I Think Clinuvel Pharmaceuticals (ASX:CUV) Might Deserve Your Attention Today
Jul 23With EPS Growth And More, Clinuvel Pharmaceuticals (ASX:CUV) Is Interesting
Apr 10Have Insiders Sold Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Recently?
Mar 06Earnings Miss: Clinuvel Pharmaceuticals Limited Missed EPS By 41% And Analysts Are Revising Their Forecasts
Feb 27What Is The Ownership Structure Like For Clinuvel Pharmaceuticals Limited (ASX:CUV)?
Feb 20Clinuvel Pharmaceuticals (ASX:CUV) Shareholders Have Enjoyed A Whopping 648% Share Price Gain
Feb 01Estimating The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jan 14We Wouldn't Rely On Clinuvel Pharmaceuticals's (ASX:CUV) Statutory Earnings As A Guide
Dec 28
Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Dec 10What You Need To Know About Clinuvel Pharmaceuticals Limited's (ASX:CUV) Investor Composition
Nov 21Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: CUV no paga un dividendo notable para el mercado Australian, por lo que no es necesario comprobar si los pagos son estables.
Dividendo creciente: CUV no paga un dividendo notable para el mercado Australian, por lo que no es necesario comprobar si los pagos aumentan.
Rentabilidad por dividendo vs. Mercado
| Rentabilidad por dividendo de Clinuvel Pharmaceuticals vs. Mercado |
|---|
| Segmento | Rentabilidad por dividendo |
|---|---|
| Empresa (CUV) | 0.3% |
| Suelo de mercado 25% (AU) | 2.6% |
| Techo de mercado 25% (AU) | 6.3% |
| Media de la industria (Biotechs) | 2.9% |
| Previsión de analistas en 3 años (CUV) | 0.6% |
Dividendo destacado: El dividendo de CUV(0.33%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Australian (2.61%).
Alto dividendo: El (0.33%) del dividendo de CUV es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Australian (6.24%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: CUV no paga un dividendo notable para el mercado Australian.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: CUV no paga un dividendo notable para el mercado Australian.